There is substantial evidence to support the concept that neoplastic transformation is associated with antigenic changes on the mammalian cell surface (7) . Identification of transformation-associated changes in cellular gene expression is an important step to elucidate the mechanism underlying transformation. Through the use of monoclonal antibodies (MAbs), a substantial number of tumor-associated antigens have been identified in rodent and human cancers (2, 5) . The majority of these cell markers are glycoproteins (4, 5) and are not cross-reactive with most tumor cells. These cell markers have been defined by MAbs obtained by xenogeneic immunizations rather than by syngeneic or autochthonous immunizations (6) . Such markers are rarely tumor specific, for they are observed at significant detectable levels on some nontumor, normal adult tissues.
Through the use of the syngeneically derived MAb-115, 44-and 200-kd oncofetal antigens (OFAs) have been immunohistochemically detected on the surface of all major classes of rodent and human tumors, on midgestational fetal cells, and on human and rodent tumor and fetal cell lines but not on a spectrum of normal neonatal or adult human and rodent tissues (7) . The 44-kd OFA glycoprotein can be manipulated to function as a tumor-associated transplantation antigen (TATA) in many syngeneic rodent tumor systems (8) . OFAs are tumor specific (not expressed on normal adult cells), but they are not germline specific as they are expressed in lymphomas, sarcomas, and carcinomas in rodents (9, 70 ). OFAs have been described as tumor-associated autoantigens in inbred, pregnant, female rodents (77) and in the tumor-immune animal (i.e., mice immunized with purified OFA or intact, irradiated OFA-positive lymphocytic lymphoma cells) and the tumor-bearing host (72). Expression of OFA as TATA may be of particular importance in the regulation and invasiveness of cancer cells and in host reactivity to autochthonous tumors (9) .
Previous studies in our laboratory (75) have shown that OFAs are early indicators of the development of primary T-cell lymphoma in irradiated RFM mice. Similarly, the availability of a recombinant OFA may also allow establishment of a sensitive and specific immunoassay for detection of antibodies in body fluids of cancer patients.
In the present study, we describe the isolation of complementary DNA (cDNA) clones in bacteria which contain embryonic mouse sequences encoding a protein with characteristics of OFA. Furthermore, we have utilized this protein to produce antibodies that specifically bind to rodent tumor and fetal cell lines. We also report the detection of antibodies against recombinant fusion protein in sera from hyperimmune and tumorbearing mice. Our results demonstrate that the isolated cDNA clones produce a distinct gene product, which is widely expressed on the surface of rodent tumor and fetal cells and represents the first characterized sequence of a true OFA that meets the original defined criteria {9, 14) .
Polyclonal anti-44 IgG antibody. Plasma membranes were prepared from mouse (BALB/cAnn) MCA-1315 fibrosarcoma cells and were solubilized in 2% /i-octylglucoside as described previously (15) . The 44-kd OFA was purified from the extract by immunoaffinity chromatography on an MAb-115 affinity column as described previously (7) . The material that eluted from the affinity column was acetone precipitated and then subjected to sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). Relevant Coomassie bluestained bands were cut from the SDS-PAGE gels and injected subcutaneously into an NZW rabbit with complete Freund's adjuvant. Subsequent injections were performed every 2 weeks for 2 months and then once a month in incomplete Freund's adjuvant. This polyclonal antibody raised to the 44-kd OFA glycoprotein will be referred to as "anti-44 IgG antibody." Anli-Escherichia coli antibodies present in most rabbits were removed from the anti-44 IgG antibody by passing the antibody through a column containing immobilized E. coli strain Y1090 bacterial lysate, obtained from 5'-3' Company (West Chester, Pa.). The preimmune rabbit serum was treated in the same manner and was used as a control.
MAb-115.
Mouse MAb-115 (IgM) was derived against syngeneic fetal cells in C57BL/6N mice, and its specificity for 44-kd-associated and 200-kd-associated epitopes has been established previously (7, 15, 16) . MAb was prepared and calibrated by immunoblot and by indirect immunofluorescence in the fluorescence-activated cell sorter (FACS) flow cytometer (17) . The methods of calibration of the FACS cytometer and plotting of the histogram have been previously described (13) .
MOPC-104E. Mouse MAb MOPC-104E (IgM), specific for the dextran-associated epitope, served as a specificity control. It was nonreactive with OFApositive fetal cells in immunoblots, in the enzyme-linked immunosorbent assay (ELISA), and in flow cytometry experiments (18) .
Anti-f3-galactosidase fusion protein antibody. The bacterial lysogens were prepared as described by Glover (19) . The fusion protein in the extracts of induced lysogen was purified by Protosorb lac z immunoaffinity adsorbent obtained from Promega Corp. (Madison, Wis.). Unfortunately, the fusion protein was not soluble, and detergents had to be added to the elution buffer. The product was run on SDS-polyacrylamide gels and visualized by staining with 0.3 M cupric chloride. The desired bands were cut, crushed, and used for immunizing a 4-month-old female NZW rabbit according to the protocol described by Sambrook et al. (20) . The rabbit was given a booster dose five times at 4-week intervals. The anti-£. coli antibodies were removed from preimmune and immune rabbit sera as described above.
Serum samples. Mice (BALB/cAnn for MCA sarcomas and RFM/UnCr for XR tumors) were immunized with OFA-positive mouse MCA-1315 fibrosarcoma cells, mouse XR11-4T lymphoblastic lymphoma cells, or mouse XR11-5T lymphoblastic lymphoma cells as described previously (8) . Blood from these hyperimmune mice was obtained without anticoagulant and was centrifuged at 4Q0g for 20 minutes at room temperature, and the serum was removed and stored at -70 'C for subsequent use. Sera from tumor-bearing mice and from control healthy mice were collected and stored similarly. The reactivity of these sera to fusion protein was tested by Western blotting.
SDS-PAGE and Immunoblotting
Protein samples were separated by electrophoresis on SDS-7.5% polyacrylamide gels (21) and either stained with Coomassie blue R250 or electrophoretically transferred to nitrocellulose membranes (22) . Nitrocellulose membranes containing protein were either stained with Ponceau S to visualize the transferred protein or incubated with specific antibodies. Nitrocellulose blots to be incubated with antibodies were blocked with 5% nonfat dry milk in TBST (10 mM Tris-HCl [pH 8.0], 155 mM NaCl, and 0.05% Tween 20) for 2 hours and then incubated with the appropriate antibody in the same buffer for 4 hours with constant agitation. Blots were then rinsed with TBST (three times, 10 minutes each) and then incubated with goat anti-mouse/rabbit (IgG, heavy chain [H] + light chain [L]) alkaline phosphatase-labeled antibody for 2 hours. After the blots were washed three times (10 minutes each) in TBST to remove unbound second antibody, nitroblue tetrazolium in combination with 5-bromo-4-chloro-3-indolyl-phosphate was added as a substrate for color development. The reaction was stopped by adding a solution of 20 mM Tris-HCl and 5 mM EDTA (pH 8.0).
Bacterial Strains and Recombinant Library Screening
E. coli strain Y1090 was used for Xgtl 1 screening, and Y1089 was used for protein production from Xgtll recombinants (19) . JM109 cells were used for production of single-stranded DNA from Bluescript II (SK+) recombinant phagemids (23). The Bluescript II phagemid vector, pUC 18, and the helper phage (VCS-M13) as well as the JM109 bacteria were obtained from Stratagene (La Jolla, Calif.). The restriction endonuclease, T4 DNA ligase, exonuclease III, S1 nuclease, sequencing primers, and Klenow DNA polymerase were obtained from Promega Corp. Bacterial media were made as described by Miller (24) . The Xgtl 1 cDNA library was obtained from Clontech Laboratories (Palo Alto, Calif.). This 5'-STRETCH, oligo dT-primed cDNA library was made from messenger RNA (mRNA) isolated from an 11.5-day whole mouse embryo (not including placenta or extraembryonic membranes). The library contained 1.4 x 10 independent clones with the insert size ranging from 0.8 to 4 kilobases (kb) (average size, 1.7 kb). Approximately 2 x 10 6 lambda phage from a Xgtl 1 cDNA library was screened with anti-44 IgG antibody by the method of Young and Davis (2526). Because we were uncertain whether or not the MAb-115 epitope was represented in the cDNA library, we chose to initially screen the library with the rabbit polyclonal anti-44-kd antibody prepared against MAb-115-purified 44-kd glycoprotein. Positive clones were isolated and validated using MAb-115. Positive clones were isolated, plaques were purified, and phage DNA was prepared by the plate lysate method (19) .
Subcloning and DNA Sequencing
DNA inserts from the isolated Xgtl 1 clones were purified from agarose gels using the Geneclean kit (Bio 101, La Jolla, Calif.) and ligated using T4 DNA ligase into appropriately digested Bluescript phagemid vector. Plasmid subclones containing progressive unidirectional deletions of inserted DNA were generated by using exonuclease HI (27) . Samples were removed at timed intervals to tubes containing SI nuclease, which removed the single-stranded tails remaining after exonuclease III digestion. After the SI nuclease was neutralized and heat inactivated, Klenow DNA polymerase was added to generate blunt ends, which were then ligated to circularize the deletion-containing plasmid. The ligation mixtures were used directly to transform competent JM109 cells. The single-stranded DNA was then generated by superinfection with helper phage VCS-M13. Single-stranded and double-stranded DNAs were cleaned up for sequencing by extraction with phenol-chloroform. Sequencing reactions for single-or double-stranded templates were carried out using Dye-primers (Applied Biosystems Inc., Foster City, Calif.) and Taq polymerase (Perkin-Elmer, Cetus, Norwalk, Conn.). A fluorescence-based DNA sequence analysis was done by using a 370-A DNA sequencer (Applied Biosystems Inc.) fitted with a 6% polyacrylamide gel and run with the manufacturer's version 1.3 software. The data from individual sequencing analyses completely covering both strands of DNA were assembled and analyzed using the GCG computer programs (University of Wisconsin at Madison).
Southern Blot Hybridization
Genomic DNA blots containing £coRI-digested genomic DNA from mouse and yeast were obtained from Clontech Laboratories as a prepared "Zooblot" nylon sheet preloaded with yeast, mouse, human, goat, chicken, and other target DNAs. The 1.6-kb insert was cut from the Xgtl 1 recombinant plasmid as DNA probe and was labeled with [ 32 P]deoxycytidine triphosphate with the use of a random primer-labeling kit (Boehringer Mannheim Co., Indianapolis, Ind.). Hybridization of the DNA probe to the genomic DNA blot was carried out as described by Sambrook et al. (20) . 
Cell Lines and Tissue Culture

Flow Cytometry Analysis
Viable cells (250 000 cells/100 |iL) were aliquoted in complete phosphatebuffered saline (PBS) (i.e., 0.01 M PBS containing 0.1% sodium azide and 2% heat-inactivated fetal calf serum) in 1.5-mL microcentrifuge tubes and pelleted at 1 lOg for 8 minutes. The cells were resuspended in 100 (XL of rabbit antifusion protein antiserum or rabbit preimmune serum and were incubated on ice with intermittent mixing. At the end of 1 hour, the cells were washed twice in complete PBS and resuspended in 50 U.L of fluorescein isothiocyanate (FITC)-conjugated second antibody (goat IgG fraction to rabbit IgG Fc fragment) or in complete PBS and returned to ice for an additional 30 minutes with intermittent mixing. Following the second incubation, the cells were again washed twice and resuspended in 500 |iL of complete PBS for flow cytometry. Fluorescence analysis on indirectly stained rodent tumor and fetal cells was performed in a FACS IV cytometer (Becton Dickinson, Mountain View, Calif.) equipped with both forward-angle and 90-degree light scatter. The 488-nm line of an argon ion laser was used at 0.3 W. FITC emission was measured at 515-545 nm by means of a 530/30-nm band-pass filter. Dead cells, erythrocytes, and the cellular debris present in the samples were removed and thus excluded from consideration by means of light scatter gating. Histograms derived from the analysis of 10 000 living cells in each sample represent gated, logarithmic fluorescence intensity versus the cell number per channel. The percentage of cells binding antibody was determined by methods described previously (13) .
Fluorescence Image Analysis
This analysis was performed on an anchored cell analyzer and sorter, ACAS 570 (Meridian Instruments, Okemos, Mich.). After staining with antifusion protein antiserum or rabbit preimmune serum and FITC-conjugated goat anti-rabbit IgG, cells on a microscope slide were positioned above the 90x oil immersion lens of the ACAS inverted microscope (Meridian Instruments). A phase-contrast image of the cells was first observed on a monochrome monitor with a CCD camera system. When the cells of interest had been selected, laser light was substituted for transmitted light. The FITC fluorochrome, conjugated to the secondary antibody, was excited with a 5-W laser (90-5; Coherent Radiation, Palo Alto, Calif.) using the 488-nm line. The cells were scanned in an X-Y pattern and exposed to brief pulses of laser light at predetermined intervals (from 0.1 to 1 |im). A 100% mirror below the microscope objective was adjusted so that fluorescence emitted by the FITC-conjugated antibodies bound to the cells was directed to a photomultiplier tube. The emitted fluorescence was detected by the photomultiplier tube using a 530/30 band-pass filter.
The resulting signals were digitized and stored in the computer. The computer displays the signal resulting from a single laser pulse as a pixel with a color value that represents the intensity of emission at that point. The computer produces a digitized, pseudo-color image from a compilation of all the signals and displays this image on a color monitor. The resulting image is similar to that observed with a fluorescence microscope with the exception that differences in fluorescence intensity are represented by a range of colors.
ELIS A for Detection of Antifusion Protein Antibodies in Murine Sera
Recombinant fusion protein (5 u.g/mL)
w as absorbed to 96-well microtiter plates (100 |lL/well), polysorb nunc-immuno plates from VWR Scientific (Atlanta, Ga.), in TBS buffer (10 mM Tris-HCl and 150 mM NaCl [pH 8.0]) overnight. This concentration was chosen following recombinant fusion protein titration with its antiserum to optimize a high signal-to-noise ratio. The following sera were tested: 56 sera from RFM mice bearing XR11-5T lymphoma, 15 sera from BALB/cAnn mice bearing MCA1315 fibrosarcoma, and 25 sera from healthy control RFM mice. The antigen solution was aspirated, and the wells were incubated for 2 hours with 1% bovine serum albumin (BSA) (Sigma Chemical Co.) in TBS to block the nonspecific binding sites on the plate. The BSA was removed, and each serum sample was added in triplicate wells. The dilution of sera used, 1:50, was determined by titration against the recombinant fusion protein. After 3 hours of incubation, the wells were washed four to five times with a solution of TBS containing 0.1% Tween-20. The plates were then incubated with goat anti-mouse IgG (H + L) alkaline phosphatase-conjugated antibody for 2 hours and washed again. p-Nitrophenylphosphate was used as the substrate, and the reaction was stopped after 30 minutes by the addition of 4 N H 2 SO 4 . Absorbance was read spectrophotometrically at a wavelength of 410 nm using a Titertek microplate reader from Flow Laboratories. All steps were carried out at room temperature. A duplicate control plate coated with 1% BSA was treated in exactly the same manner with each assay, and the absorbance values obtained were subtracted from the test results to exclude any nonspecific binding. Statistical analyses were done using the Mystat program (31) . ELISA values above the mean + 2 SD of the normal sera were considered positive.
Results
Isolation and Purification of cDNA Clones
A rabbit polyclonal antibody was raised to the 44-kd protein in its SDS-PAGE band-purified form as described in the "Materials and Methods" section. This polyclonal antibody (anti-44 IgG) specifically recognized 44-and 200-kd OFAs in immunoblots of partially purified and enriched membrane extracts containing either 44-kd OFA ( Fig. 1, A; lane 2) or 200-kd OFA ( Fig. 1, B ; lane 1). Rabbit preimmune serum did not show any reactivity ( Fig. 1, B ; lane 2).
This anti-44 IgG antibody was used to screen a mouse embryo X-gtl 1 cDNA library. The screening of 2 x 10 6 recombinant plaques resulted in the identification of two individual plaques producing hybrid protein that demonstrated specific binding to anti-OFA antibody. Both independent recombinant clones were plaque purified and were found to be reactive with both rabbit anti-44 IgG antibody and MAb-115. Restriction analysis of these two clones demonstrated that they contained inserts of 1.2 and 1.7 kb (data not shown). Several other isolated plaques were found to be false-positives.
Production and Analysis of Fusion Polypeptides
The size of the fusion protein that accumulates in Y1089 cells containing the A.gtll recombinant was investigated by lysis of the cells in Laemmli's sample buffer (21) . The lysate was subjected to SDS-PAGE, and the gels were stained with Coomassie blue R (Fig. 2, A) . A band exhibiting the mobility predicted for the p-galactosidase OFA fusion protein was observed at 180 kd ( Fig. 2, A; lane 4) . A similar band was absent from the controls containing lysates from cells only ( Fig. 2, A ; lane 2) and lysates from cells containing Xgtl 1 without an insert ( Fig. 2, A; lane 3) .
When the proteins were electroblotted from the SDSpolyacrylamide gels to a nitrocellulose membrane and probed with anti-OFA antibodies (Fig. 2, B) , a single band was observed with MAb-115 (lane 5), which was absent in the control MOPC-104E antibody (lane 4). The rabbit anti-44 IgG polyclonal antibody did bind to the 180-kd band ( Fig. 2, B ; lane 3), but some nonspecific binding to other E. coli proteins was still observed. Similar nonspecific binding was observed with the control preimmune serum ( Fig. 2, B ; lane 2).
Isolated cDNA Clones Representing Part of Mouse Genome
In order to determine whether the isolated cDNA clones represent some part of the mouse genome, the prepared "Zooblot" nylon sheet was probed with a 32 P-labeled 1.67-kb fragment isolated from the mouse embryo DNA library (for details, see "Materials and Methods" section, "Southern Blot Hybridization"). The blot hybridization revealed that the 1.67-kb DNA fragment hybridized to mouse DNA and did not bind to yeast DNA (data not shown). These data show that the clones obtained in this study were not yeast in origin, negate concerns from the recent report (32) regarding the cDNA libraries used from Clontech Laboratories, and confirm that the clones isolated by us represent part of the mouse genome.
Identification of cDNA Inserts Coding for OFA
The screening of a mouse embryo A.gtll expression library with an antibody that specifically recognizes 44-kd and 200-kd OFA polypeptides in tumor and fetal cells yielded the identification of two positive clones. Subcloning and sequencing of the longer 1.67-kb clone revealed a single, long, open reading frame of 1638 bases, beginning with GAA at bases 1-3 and ending with TAG at bases 1635-1638. Sequence analysis of the clone revealed that it contained 1638 base pairs (bp), of which an open reading frame was identified encoding a protein of 545 amino acids. When coupled with the approximately 120-kd P-galactosidase-coding sequence of the Xgtll vector, this sequence would produce a P-galactosidase putative OFA fusion protein of 180 kd in apparent molecular weight. This 180-kd fusion protein is specifically recognized by the anti-44 IgG used to screen the mouse embryo library. The nucleotide and deduced amino acid sequences are shown in Fig. 3 (Genbank accession No. U06662).
It is assumed that ATG at nucleotides 43-45 is not a translation start site. There were no signs of a conserved motif that might uniquely identify AUG initiator codon based on conformity to the consensus sequence CCACCAUG (33) . Therefore, the 
first methionine codon (42 bp from the 5' end) represented an internal methionine, and it was preceded by a 14-amino-acidcoding segment of DNA that could be a part of the 5' end of the OFA message which was missing. This was the only open reading frame beginning with an AUG and ending at a translation termination codon in any reading frame. The open reading frame was surrounded by 29 bp of a 3' untranslated sequence, and there was no evidence of a characteristic signal sequence for polyadenylation at the 3' end of the clone. Searches of nucleotide databases indicated that this sequence has not been previously reported (34) . Searches of the amino acid database (TFASTA) of the deduced amino acid sequence did not show significant homology with any known protein (35J6). Comparison with other proteins revealed no clear sequence similarity with known tumor antigen structures, homologous immunoglobulins, or some other proteins of known sequence (57). The second cDNA clone was shorter, containing a 1.26-kb insert, but otherwise it matched exactly the first clone at the 3' end.
The hydropathy profile of the predicted protein (data not shown) was generated by the program Peptidestructure, available in the GCG package which uses the algorithm of Kyte and Doolittle (38) . The curve obtained revealed a residue-specific hydrophobic index over a window of nine residues (data not shown). The line in the upper and lower halves of the frame, indicating hydrophobic and hydrophilic regions, respectively, illustrated the hydrophobic peaks associated with this protein.
Each peak could potentially span the cell membrane. Amino acid analysis of these peaks revealed strings of hydrophobic amino acids bordered by the charged amino acid residues clustered between the peaks. Further analysis of the primary structure of this protein to locate possible signal peptide sequences (39) for the direction of protein into membrane was unsuccessful. The predicted protein sequence included 10 potential glycosylation sites represented by Asn X Ser/Thr. These findings are consistent with those of previous studies (8, 16) which have demonstrated that OFA is a glycoprotein.
Isolated Clones Representing a Part of OFA
In order to determine whether the isolated cDNA clone contained sequences encoding OFA, a rabbit polyclonal antibody was raised against the recombinant fusion protein and was used to detect specific binding to native OFAs present in extracts of murine tumors. The 180-kd fusion protein synthesized by bacteria was used to generate a polyclonal antibody; as shown in Fig. 4 , this anti-180-kd fusion protein antibody exhibited specific binding with both native 44-kd OFA (Fig. 4, A; lane 1) and 200-kd OFA (Fig. 4, B ; lane 1) in partially purified and enriched membrane extracts of murine lymphocytic lymphoma containing either 44-or 200-kd OFA. This strong binding to 44-or 200-kd OFA was not observed with preimmune serum (Fig.  4, A and B; lane 2) or with antibodies directed against native Pgalactosidase (not shown). Faint bands seen at 10, 31, and 60 kd (Fig. 4, A ; lane 1) were presumably due to nonspecific crossreactivity of anti-£. coli antibodies present in the rabbit antifusion protein antiserum even after absorption with E. coli proteins. This nonspecific binding could be removed by passing the antiserum several times through the column of immobilized Y1090 bacterial lysate. These experiments indicate that the 545 amino acids encoded by the isolated cDNA clone represent a part of the OFA. Ten potential glycosylation sites have been underlined on the deduced amino acid sequence. Glycosylation sites are predicted for sites where the residues have composition Asn X Ser or Asn X Thr. When X is aspartic acid, tryptophan, or proline, the site is taken to be a weak glycosylation site; otherwise, it is a strong glycosylation site.
Specific Binding of Rabbit Antifusion Protein Antibody to Rodent Tumor and Fetal Cell Lines
We wanted initially to determine by use of the FACS IV flow cytometer whether the antiserum raised against the recombinant fusion protein would distinguish several OFA-positive rodent tumor and fetal cell lines (77) from normal (OFA-negative) tissues ( ) OFA was separated on SDS-7.5% polyacrylamide gel and then transferred to nitrocellulose filters. After being blocked with 5% nonfat dry milk, the nitrocellulose filters were incubated with antibody directed against j}-galactosidase fusion protein (panels A and B, lane 1) or rabbit preimmune serum (panels A and B, lane 2). After being washed, the blots were incubated with alkaline phosphatase-labeled goat anti-rabbit IgG antibody. The bound antibody was localized by addition of the substrate nitroblue tetrazolium-5-bromo-4-chloro-3-indolyl-phosphate, as described in the "Materials and Methods" section.
antibodies, confirming the absence of OFA. Other OFA-positive (reported in this study) murine hepatoma (Hepa 1-6) and simian virus 40-transformed mouse embryo (MOP-8) cell lines showed strong reactivity with rabbit antifusion protein antibody. Midgestational hamster fetal cells, known to express 44-kd OFA (7), displayed significant reactivity to antifusion protein antibody. By fluorescence microscopy with the use of the ACAS 570 anchored cell analyzer and sorter, direct visual inspection of the cell preparation confirmed the presence of immunofluorescence on living tumor cell surfaces using the rabbit antifusion protein antibody (Fig. 6) Fig. 6 ) revealed that the antibodies bound or were distributed in small, discrete, localized collections on the cell surface. This was not seen with the control preimmune serum (panel a, Fig. 6 ). XR11-4T (panel d, Fig. 6 ) and XR11-5T (panel f, Fig. 6 ) lymphocytic lymphoma cell lines also showed binding of antifusion protein antiserum as pockets of intense antibody surrounded by larger, antigen-free areas at the cell perimeter reflecting "capping," which is characteristic of lymphocytes. When the same cells were exposed to preimmune serum, they gave only background fluorescence (panels c and e, Fig. 6 ). These results illustrate that the antifusion protein antibody recognizes an antigen which is present on rodent tumor and fetal cells but not on normal tissues.
Immunoreactivity of Purified Recombinant Fusion Protein
We investigated the presence of antibodies against recombinant fusion protein in sera from hyperimmune mice and tumor-bearing mice by Western blot analysis using the recombinant fusion polypeptide produced in E. coli as an antigen. The immunoblots shown in Fig. 7 revealed that sera from MCA-1315 tumor-bearing mice (lane 2) or mice immunized with OFA-positive lymphocytic lymphoma cells (lane 3) bound specifically to recombinant OFA, whereas sera from normal mice (lane 4) did not show any reactivity. These antibodies to recombinant fusion protein were not detected when a native fjgalactosidase or a totally unrelated f3-galactosidase fusion protein, lac I/z, was used, demonstrating the specific detection of antibodies in sera from tumor-bearing mice and hyperimmune mice by recombinant fusion polypeptide (data not shown).
Using ELISA, we have further utilized the recombinant fusion protein to detect antibodies in sera from tumor-bearing mice. We tested 56 serum samples from mice with XR11-5T lymphocytic lymphoma, 15 from mice with MCA-1315 fibrosarcoma, and 25 from matched normal control mice. The data are presented in Fig. 8 . Antibodies to the recombinant fusion were detected in 76.6% of mice with XR11-5T lymphocytic lymphoma and 80% of mice with MCA-1315 fibrosarcoma as compared with background levels detected in normal mice. The differences between sera from tumor-bearing mice and sera from normal mice were highly significant (/><.0005).
Discussion
Coggin (9, 14) has outlined the characteristics of a true OFA. True OFAs are 1) expressed in embryo or fetus and distinctly phased from expression in normal term fetus and in normal adult tissues; 2) immunogenic in syngeneic hosts, inducing both antibody and T-lymphocyte protective responses against OFA- Channel Number (Relative Fluorescence Intensity) Fig. 5 . Row cytometric analysis of OFA-positive tumor and fetal cell lines by staining with antifusion protein antiserum. Cells were first incubated with antifusion protein antiserum or control, rabbit preimmune serum, followed by reaction with FITC-conjugated goat anti-rabbit IgG and analyzed in FACS IV. In these histograms, the abscissa represents logarithmic fluorescence and the ordinate is the relative number of cells at each level of fluorescence intensity. In each histogram, the thin line denotes the background staining with (control) rabbit preimmune serum, and the thick line represents specific staining with antifusion protein antiserum. Ten thousand cells were analyzed from each sample, and the percentage of cells binding the antifusion protein antibody was determined by flow cytometry as described in the "Materials and Methods" section. (Fig. 1) . They did not show any reactivity to native P-galactosidase or an unrelated, lac l/z, p-galactosidase fusion protein. The 1.67-kb fragment was subcloned in another expression vector, pUC 18. Since the cloning site on this plasmid is near the beginning of the LacZ gene, it would add in only a small leader peptide to the fusion protein, compared with the entire 1007 amino acids of the p-galactosidase. The protein produced was analyzed by Western blotting; both polyclonal and monoclonal anti-OFA antibodies specifically detected the foreign protein that was produced, demonstrating that they were not binding to a false epitope created by fusion of P-galactosidase to a foreign protein (data not shown).
Following the development of a rabbit polyclonal antibody against the recombinant fusion protein, we determined the expression of OFA on several murine tumor and fetal cell lines in an effort to address the prediction that this antibody would recognize an antigen present on tumor cells and fetal cells but not on normal cells. In the present study, using flow cytometry, we have documented by direct means that antibody to recombinant fusion protein specifically recognized an antigen present on the surface of tumor and fetal cells. We observed no reactivity with normal thymus, liver, or spleen. These findings conform to our prediction and support the observation that antibodies raised to the fusion protein show characteristics similar to those of MAb-115. This antifusion protein antibody binds specifically to the sarcomas and lymphomas as does MAb-115 (7), and the epitope recognized is widely expressed on rodent tumor and fetal cells and is not present in normal adult tissues.
We (7, 17, 18, (40) (41) (42) had previously shown that OFA expressed on fetal cells stimulates both humoral and cell-mediated immune responses in pregnant rodents, whereas OFA expressed on tumor cells has a similar immunogenicity in tumor-bearing rodents. have demonstrated that sera from human cancer patients contain autoantibodies specific for the autologous tumor cells. We have demonstrated that sera from tumor-bearing or hyperimmunized mice, i.e., mice immunized with intact, irradiated OFA-positive lymphocytic lymphoma cells, contained antifusion protein activity (Fig. 7) . Sera from normal, age-matched mice did not contain any detectable antibody to this protein. Many serum samples from mice with small sarcomas that express OFA also bound specifically to the recombinant fusion protein expressed in the nonglycosylated OFA polypeptide from recombinant E. coli lysates. This result suggested that a 545-amino-acid isolated protein, encoded by a 1.67-kb insert, shares an antigenic determinant(s) with OFA.
Another line of evidence that the isolated cDNA contained sequences encoding OFA was derived from the fact that the antibodies raised to the recombinant mouse embryo polypeptide specifically recognized native 44-and 200-kd OFAs in partially purified membrane extracts of murine lymphocytic lymphoma containing either 44-or 200-kd OFA (Fig. 4) . Both of these glycoproteins, 44-and 200-kd OFAs, have been purified and partially characterized using protocols described previously {8, 16) . It was noted that polyclonal serum derived from a rabbit immunized with the p-galactosidase fusion protein had no reactivity against |3-galactosidase, yet it reacted strongly with both native 44-and 200-kd OFAs on immunoblots. These results provided strong evidence that the isolated protein is a part of OFA.
The analysis of the nucleotide and deduced amino acid sequences shows that the isolated protein is composed of 545 amino acids and does not have any significant sequence similarities with proteins in databases. Whether this protein is similar or identical to native OFAs expressed on tumor and fetal cells remains to be determined, but the criteria used for selection of this clone strongly favor its relationship to OFA glycoproteins. First, the antibodies used to isolate the clone either were made against the purified 44-kd OFA (polyclonal anti-44 IgG) or were derived against syngeneic midgestational mouse fetal cells expressing the 44-kd OFA glycoprotein (MAb-115). Second, the clone was isolated from a cDNA library made from an 11.5-day mouse embryo which synthesizes the maximum amount of this protein (7) . Third, the antibody raised against the recombinant fusion protein specifically bound to the same spectrum of tumor and fetal cells as MAb-115. Fourth, the antibodies present in tumor-bearing or tumor-immune mice specifically bound recombinant polypeptide. Fifth, as expected, the hydropathy profile of the predicted protein possessed characteristics typical of transmembrane proteins. Sixth, no significant homology was found to the gene products compiled in databases. Finally, the strongest line of evidence came from the 12 3 4 Fig. 7 . Immunoreactivity of sera from hyperimmune and tumor-bearing mice with recombinant fusion polypeptide. P-Galactosidase fusion protein was purified by affinity chromatography as described in the "Materials and Methods" section. Following SDS-PAGE, the proteins were transferred to nitrocellulose filters. The blots were blocked with 5% nonfat dry milk and then incubated with sera from normal mice (lane 4), hyperimmune mice (lane 3), or tumor-bearing mice (lane 2) for 4 hours with constant agitation. After being washed, the blots were incubated with alkaline phosphatase-labeled goat anti-mouse IgG for 2 hours, and the substrate was then added for color development as described in the "Materials and Methods" section. Lane I shows molecular weight standards. Recombinant fusion protein was absorbed to 96-well microtiter plates. After being blocked with BSA, corresponding serum samples were added and the presence of antifusion protein antibody was detected by addition of alkaline phosphatase-conjugated antibody and substrate as described in the "Materials and Methods" section. The absorbance was read spectrophotometrically at a wavelength of 410 nm. P value = individual group versus control. Positive cases > mean + 2 SD of control (indicated by dotted line). OD = optical density.
fact that antibodies raised to the recombinant fusion protein specifically recognized native 44-and 200-kd OFA glycoproteins in extracts of murine lymphocytic lymphoma. Collectively, these data suggest that the isolated cDNA either contains sequences encoding a part of OFA glycoprotein or belongs to a part of a closely related family of genes. The protein sequence of the native OFA was not available for comparison with the deduced amino acid sequence of the isolated clone. Initial attempts to sequence the 44-kd OFA were unsuccessful, since it was blocked at the N-terminal end. This cDNA clone lacked sequences corresponding to the amino-terminal region. Barsoum and Coggin (16) A recent report (32) has revealed a troubling and potentially widespread problem of yeast contamination of libraries supplied by Clontech Laboratories. Clones reported in the present study were isolated from a mouse embryo library purchased from Clontech. Even though Clontech (46) claims that low-level yeast contamination does not affect quality or functionality of the library when it is used for screening with a specific DNA or antibody probe, ambiguity may arise when screening is done with a probe of significant homology to yeast sequences or when it is used for massive direct sequencing purposes. Fortunately, a specific anti-OFA antibody was used to isolate the clones in the present study. But in an effort to further understand the implications of the reported contamination, EcoRI-digested genomic DNA from the mouse and from yeast (S. cerevisiae) was probed with a 1.67-kb insert, which gave a positive band with mouse DNA but did not produce positive signals when it was used to probe yeast genomic DNA. This observation confirmed that the cDNA clones isolated from a mouse embryo library did belong to the mouse. However, Northern blot hybridization on total RNA and poly-A RNA blots using the 1.6-kb cDNA fragment as a probe failed to yield any detectable signal in well-controlled trials. The presence of a distinctive 5-kb band on the Southern blot performed on mouse genomic DNA clearly indicated the presence of this gene (data not shown). The low level of the OFA encoding RNA is rather linked to its own processing mode based on the data at hand. We are exploring the growth conditions that can allow us to raise the amount of that specific mRNA to detectable levels. In addition, more sensitive methods for detection of RNA, such as reverse transcriptase-polymerase chain reaction and ribonuclease protection assays, will be applied in the search for the full gene.
Identification of transformation-associated changes in cellular gene expression is an important step in the elucidation of the mechanism underlying malignant transformation. It is generally assumed that transforming genes are transcriptionally inactive in normal tissue and that cell transformation is a consequence of their activation, by whatever means. The role of the OFA glycoprotein in malignant transformation is unclear at present. It is clear, however, that it appears in tumor and embryonal cell populations. In primary, radiation-promoted T-cell lymphomas, the OFA proved to be expressed weeks to months prior to histologic lymphomas and was a reliable predictor of lymphoma occurrence in the thymus (75). Previous studies in our laboratory (40) , utilizing MAb-115, have shown that OFA is an immunogenic TATA and represents a general, species-conserved, tumor marker that is not found in normal adult tissues of rodents or humans. It should be distinguished as a true OFA from the class of differentiation antigens like carcinoembryonic antigen and oc-fetoprotein by several criteria based upon conclusions drawn from many previous in vivo immunogenicity studies (9J4J0A0).
The availability of this cDNA, which encodes a protein present only on tumor and fetal cells, provides a direct means to assess the biological characteristics of malignant tissue, which can be assayed by biochemical, histochemical, and molecular methods. The cDNA isolated in the present investigation is only a partial clone. It lacks the 5' end that may code for the aminoterminal portion of the OFA. Using the mRNA isolated from tumor cells expressing the OFA, we hope to determine the upstream sequence above the 1.7-kb fragment presently cloned. We are actively seeking to obtain a sufficient amount of 44-and 200-kd OFAs to attempt sequencing of the chemically or enzymatically cleaved form to permit peptide sequencing. The cloning of the entire OFA gene and presumed promoter region will allow further investigation of the developmental regulation and function of this protein.
